IMPEL PHARMACEUTICALS INC (IMPL) Stock Cash Flow
NASDAQ:IMPL - Nasdaq - US45258K1097 - Common Stock - Currency: USD
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -91.56M | -106.31M | -76.54M | -45.80M | -41.86M | |||
| Depreciation Amortization | 820.00K | 1.20M | 1.09M | 1.08M | 720.00K | |||
| Change In Working Capital | -6.24M | -13.01M | 2.21M | 1.54M | 3.21M | |||
| Interest Paid | N/A | 4.59M | 1.36M | N/A | N/A | |||
| Other non cash items | 11.73M | 24.48M | 6.87M | 4.00M | 1.44M | |||
| OPERATING CASH FLOW | -85.24M | -93.64M | -66.36M | -39.18M | -36.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.07M | -1.38M | -410.00K | -1.78M | -1.52M | |||
| INVESTING CASH FLOW | -2.07M | -1.38M | -410.00K | -1.78M | -1.52M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 14.59M | 26.58M | 9.70M | 0.00 | |||
| Stock Issued/Repurchased | 4.27M | 4.46M | 121.31M | 1.36M | 20.00K | |||
| Other Financing Activity | 400.00K | 48.42M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 4.66M | 67.46M | 147.89M | 11.06M | 20.00K | |||
| CHANGE IN CASH | -82.65M | -27.56M | 81.12M | -29.90M | -37.99M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -85.24M | -93.64M | -66.36M | -39.18M | -36.49M | |||
| Capital Expenditure | -2.07M | -1.38M | -410.00K | -1.78M | -1.52M | |||
| FREE CASH FLOW | -87.31M | -95.02M | -66.77M | -40.96M | -38.01M | |||
All data in USD